Showing 4,621 - 4,640 results of 5,020 for search 'Europop~', query time: 2.48s Refine Results
  1. 4621

    Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France by Huamao Mark Lin, Keith L. Davis, James A. Kaye, Katarina Luptakova, Saurabh P. Nagar, Mohamad Mohty

    Published 2019-01-01
    “…Limited data are available from real-world practices in Europe describing prevailing treatment patterns and outcomes in relapsed/refractory multiple myeloma (RRMM), particularly by cytogenetic risk. …”
    Get full text
    Article
  2. 4622

    Morphological and molecular characterization of a Sarcocystis bovifelis-like sarcocyst in American beef by Aditya Gupta, Larissa S. de Araujo, Andrew Hemphill, Asis Khan, Benjamin M. Rosenthal, Jitender P. Dubey

    Published 2024-12-01
    “…Although S. hominis has been reported as prevalent in Europe, the occurrence of thick-walled species in the US remains poorly known. …”
    Get full text
    Article
  3. 4623

    Adaption oder Anpassung? Umweltbewusstsein in der Region um den Plattensee/Balaton (Adaptation or a Change in Attitude? Environmental Awareness in the Region of Lake Balaton) by Magdolna Leveleki

    Published 2016-04-01
    “…We have collected empirical data in a region of Eastern-Central Europe that is especially sensitive to the effects of climate change both from an ecological and a social point of view. …”
    Get full text
    Article
  4. 4624

    Newborn screening for congenital hypothyroidism: worldwide coverage 50 years after its start by Marta Arrigoni, Nitash Zwaveling-Soonawala, Stephen H LaFranchi, A S Paul van Trotsenburg, Christiaan F Mooij

    Published 2025-01-01
    “…Results: Currently, 29.6% of children worldwide are screened for CH. Europe, North America, Oceania, China, Japan and Israel have efficient programs with optimal coverage. …”
    Get full text
    Article
  5. 4625

    Bridging the gap: attitudes and practices toward complementary and alternative medicine among oncology patients and healthcare professionals in Croatia by Ljerka Armano, Vanja Vasiljev, Tomislav Rukavina, Denis Juraga, Aleksandar Racz, Aleksandar Racz, Vanja Tešić, Vanja Tešić, Vanja Tešić

    Published 2025-01-01
    “…The prevalence of complementary and alternative medicine (CAM) use among oncology patients ranges from 30 to 80%, particularly higher in the United States compared to Europe. However, limited research exists on the attitudes of healthcare professionals and oncology patients toward CAM, especially within Western evidence-based medical settings. …”
    Get full text
    Article
  6. 4626

    Kinesiotherapy for Post-stroke Rehabilitation: Analysis of Characteristics of Clinical Trials in the Past 20 Years Based on Clinical Trials Registry Platform by WANG Hui, FENG Yuting, YU Yongpei, HU Chenhua, TAO Liyuan

    Published 2022-10-01
    “…In terms of geographical distribution, most of the studies were conducted in the Americas (35.97%, mainly in the United States), but the number of registered studies in the Americas declined in recent 10 years, while the number of registered studies in Europe and Asia increased, with statistical difference among different geographical locations (<italic>P</italic>&lt;0.001). …”
    Get full text
    Article
  7. 4627

    Comparative Analysis of the Views of Rodney Stark and Bryan Wilson in the Context of Secularisation Paradigms by Büşra Kutluay Çelik

    Published 2024-12-01
    “…On the other hand, Wilson argues that subjective religiosity remains high in Europe, suggesting that secularisation has significantly impacted traditional religious groups and contributed to the formation of new cults. …”
    Get full text
    Article
  8. 4628

    A Cross-sectional Survey of Physicians to Understand Biomarker Testing and Treatment Patterns in Patients with Prostate Cancer in the USA, EU5, Japan, and China by Christian Gratzke, Himani Aggarwal, Jeri Kim, Holly Chaignaud, Sabine Oskar

    Published 2025-01-01
    “…This work aims to assess genetic/genomic testing patterns and methods, including for homologous recombination repair mutation (HRRm), and treatment decisions among physicians caring for patients with PC across the USA, Europe, and Asia. Methods: A cross-sectional online survey of physicians treating patients with advanced PC was administered in the USA, France, Germany, Italy, Spain, UK, Japan, and China. …”
    Get full text
    Article
  9. 4629

    Elevated Cerebrospinal Fluid Neopterin Concentration Is Associated with Disease Severity in Acute Puumala Hantavirus Infection by Timo Hautala, Terhi Partanen, Tarja Sironen, Saara-Mari Rajaniemi, Nina Hautala, Olli Vainio, Olli Vapalahti, Heikki Kauma, Antti Vaheri

    Published 2013-01-01
    “…Nephropathia epidemica (NE) caused by Puumala hantavirus (PUUV) is the most common hemorrhagic fever with renal syndrome (HFRS) in Europe. The infection activates immunological mechanisms that contribute to the pathogenesis and characteristics of the illness. …”
    Get full text
    Article
  10. 4630

    One Health preparedness and response for mosquito-borne viruses: a stakeholder- and social network-analysis in the Netherlands by Pauline A. de Best, H. Broekhuizen, R. S. Sikkema, M. P. G. Koopmans, A. Timen

    Published 2025-01-01
    “…Abstract Background The emergence of mosquito-borne viruses (MBVs) in Europe emphasizes the need for preparedness and response plans. …”
    Get full text
    Article
  11. 4631
  12. 4632

    Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel by Miquel Bernardo, Marina Díaz Marsá, Ana González-Pinto, Manuel Martín Carrasco, Víctor Pérez Sola, Pilar Alejandra Sáiz, Eduard Vieta, Marta Torrens, Celso Arango, Benedicto Crespo-Facorro

    Published 2025-01-01
    “…Lurasidone is an atypical antipsychotic agent which is approved in Europe for the treatment of schizophrenia in adults and adolescents (13–17 years). …”
    Get full text
    Article
  13. 4633
  14. 4634

    The contribution of intellectual capital to banks' competitive and financial performance: The evidence from Poland by Monika Klimontowicz, Justyna Majewska

    Published 2022-01-01
    “…To the authors' best knowledge, this is the first study to examine empirically the relationship between intellectual capital, environment, competitive performance, and efficiency in a transformed banking market in Europe, which analyses the IC contribution over a few years' perspectives.…”
    Get full text
    Article
  15. 4635

    The complete mitochondrial genome of Gyrodactylus pseudorasborae (Platyhelminthes: Monogenea) with a phylogeny of Gyrodactylidae parasites by Xinyi Zeng, Ye Li, Yang Liu, Yaoying Chen, Yajing Liu, Mengwei Song, Tao Chen

    Published 2025-01-01
    “…Gyrodactylus pseudorasborae Ondračková, Seifertová & Tkachenko, 2023 widely distributed in Europe and China, although its mitochondrial genome remains unclear. …”
    Get full text
    Article
  16. 4636
  17. 4637

    Clinical Study and Finite Element Analysis on the Effects of Pseudo‐Patella Baja After TKA by Shenghu Jiang, Wenxing Wei, Mingyang Li, Shengliang Zhou, Yi Zeng, Bin Shen

    Published 2025-01-01
    “…Clinical evaluation was performed using the visual analogue scale (VAS), the Hospital for Special Surgery (HSS), the Western Ontario McMaster University Osteoarthritis Index (WOMAC) scoring systems, the 5‐Level EuroQol Generic Health Index (EQ‐5D‐5L), the Forgotten Joint Score‐12 (FJS‐12), and patient satisfaction. …”
    Get full text
    Article
  18. 4638
  19. 4639

    Cardiovascular risk assessment: Missing albuminuria contributing to gender inequality by Patricia de Sequera, Javier Arias, Borja Quiroga, María Benavent, Fabio Procaccini, Iago Romero, Guillermo López, Javier Diez, Alberto Ortiz

    Published 2025-01-01
    “…Las guías de la Sociedad Europea de Cardiología (SEC), la Asociación Renal Europea (ERA) y la Sociedad Española de Nefrología (SEN), en colaboración con 15 sociedades científicas, recomiendan evaluar la albuminuria en todas estas poblaciones.Hemos evaluado la práctica clínica actual con respecto a la evaluación de los factores de riesgo de ECV (presión arterial, albuminuria, colesterol sérico, glucemia y creatinina) en diferentes poblaciones adultas de usuarios de salud, analizando los resultados por separado para los hombres y las mujeres, dada la evidencia reciente sobre las diferencias de género en el reconocimiento, el seguimiento y el tratamiento de la ERC. …”
    Get full text
    Article
  20. 4640

    Cardiovascular risk assessment: Missing albuminuria contributing to gender inequality by Patricia de Sequera, Javier Arias, Borja Quiroga, María Benavent, Fabio Procaccini, Iago Romero, Guillermo López, Javier Diez, Alberto Ortiz

    Published 2025-01-01
    “…Las guías de la Sociedad Europea de Cardiología (SEC), la Asociación Renal Europea (ERA) y la Sociedad Española de Nefrología (SEN), en colaboración con 15 sociedades científicas, recomiendan evaluar la albuminuria en todas estas poblaciones.Hemos evaluado la práctica clínica actual con respecto a la evaluación de los factores de riesgo de ECV (presión arterial, albuminuria, colesterol sérico, glucemia y creatinina) en diferentes poblaciones adultas de usuarios de salud, analizando los resultados por separado para los hombres y las mujeres, dada la evidencia reciente sobre las diferencias de género en el reconocimiento, el seguimiento y el tratamiento de la ERC. …”
    Get full text
    Article